NFA
ATYR

Nationwide Fund Advisors’s aTyr Pharma ATYR Stock Holding History

Nationwide Fund Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7
Closed – – 3218
2016
Q4 		$0 Sell
7
-1,436
-100% -$58.9K ﹤0.01% 3225
2016
Q3 		$64K Buy
1,443
+71
+5% +$3.07K ﹤0.01% 3014
2016
Q2 		$53K Buy
1,372
+1,093
+392% +$50.8K ﹤0.01% 3067
2016
Q1 		$15K Hold
279
– – ﹤0.01% 3119
2015
Q4 		$38K Hold
279
– – ﹤0.01% 3019
2015
Q3 		$40K Hold
279
– – ﹤0.01% 3057
2015
Q2 		$72K Buy
+279
New +$86.6K ﹤0.01% 3070

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's ATYR Position: Q1 2017 in Review

Nationwide Fund Advisors sold out of aTyr Pharma (ATYR) in Q1 2017, closing a stake of 7 shares.

Nationwide Fund Advisors first reported a position in ATYR in Q2 2015 and held it in 7 quarters. The position peaked at $72K in Q2 2015. 39 funds tracked by Wall St. Rank hold ATYR as of Q1 2017.

  • Nationwide Fund Advisors reported no remaining aTyr Pharma position as of Q1 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7 aTyr Pharma shares in Q1 2017.
  • Nationwide Fund Advisors first reported a position in aTyr Pharma in Q2 2015 and held it in 7 quarters.
  • Nationwide Fund Advisors's aTyr Pharma position peaked at $72K in Q2 2015.
  • 39 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2017.

Based on Nationwide Fund Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.